Shinpoong Pharmaceutical said Thursday it has sought a regulatory nod to change the phase 3 clinical trial plan using Pyramax, its antimalarial treatment, as a Covid-19 treatment.The primary endpoint of the existing clinical trial plan was set up as the proportion of subjects in hospitalization or d
Johnson & Johnson’s Head of JLABS in Asia Pacific, Sharon Chan, moderated DTx Asia’s afternoon session on day two regarding digital therapeutic start-ups in the APAC region on Wednesday at the Novotel Ambassador Hotel in Seoul.JLABS is an incubator for start-ups in the pharmaceutical, medical device
The government has decided to respond to the recent Covid-19 resurgence without upgrading social distancing measures by increasing the use of oral medicines and protecting facilities vulnerable to infection.Confirming that a Covid-19 resurgence is in progress, the Central Disease Control Headquarter
The Korean biopharmaceutical industry is actively recruiting foreign executives to launch their products in the global market.According to industry watchers, Korean biopharmaceutical companies are pursuing new drug development and commercialization overseas rather than in Korea due to excessive dome
The share of doctors indicted and criminally punished for professional negligence resulting in death or injury in Korea is higher than in other countries, such as Japan, Germany, and the U.K.Every year, 762 doctors are charged with professional negligence resulting in death or injury in Korea, accor
An Ulsan National Institute of Science and Technology (UNIST) research team said it has developed a subcutaneous sensor that can measure blood glucose levels without finger pricks.Diabetes mellitus is a disease in which fasting blood glucose levels are maintained above 126 mg/dL, which is higher tha
Day two of DTx Asia began with experts in the APAC region discussing different ways to integrate digital therapeutics (DTx) into healthcare and its respective opportunity costs, at the Novotel Ambassador Hotel in Seoul on Wednesday.The panelists included EverEx Founder & CEO Chan Yoon who served as
In the aftermath of the death of a nurse at Asan Medical Center due to stroke, the Ministry of Health and Welfare is preparing comprehensive essential healthcare measures, including the reform of regional cardio-cerebrovascular centers.The plan calls for, among others, bolstering the capacities of t
Binex was suspended from manufacturing all synthetic drugs at its Busan plant due to violating the Pharmaceutical Affairs Act.Binex maintains that the discipline would have little effect on its marketing. However, given the broad scope of products hit by the administrative disposition, sales losses
Dong-A ST said it plans to incorporate NeuroBo Pharmaceuticals, a U.S. pharmaceutical company, as a subsidiary in December.Dong-A ST plans to finalize the process after becoming the largest shareholder of NeuroBo with a 50.8 percent stake in the company through the latter's extraordinary shareholder
The number of new confirmed Covid-19 cases on Tuesday surpassed 60,000, the highest since mid-September.According to the KDCA, Korea added 62,273 new Covid-19 infections, including 52 cases from abroad, bringing the total caseload to 25,919,183.The figure on Tuesday is the highest number in 54 days
Neurophet said it presented the research results on brain image analysis technology and brain disease prediction method using artificial intelligence (AI) during the International Congress on Magnetic Resonance Imaging 2022 (ICMRI 2022) in Seoul last week.During the conference, the company presented
A Korean government official in charge of reviewing digital health devices outlined three major criteria for the regulator’s review of digital therapeutics (DTx) products at DTx Asia in Seoul on Tuesday.In the afternoon session of DTx Asia, Han Young-min, Assistant Director of Digital Health Devices
Humans are conquering cancer like they conquered the moon. What will be the disease accompanying humankind until the last day of Earth, then? Of numerous illnesses, many medical experts point to obesity. Why do they pick obesity, which can be solved by “just getting rid of fat,” among all the rare,
Asia-Pacific (APAC) medical and pharmaceutical fields have increased their presence globally in recent years. Such exponential growth has made the region one of the major players in the world, with various global pharmaceutical companies targeting the area as their future growth engine. Against this
DTx Asia, a conference inviting healthcare companies specializing in digital therapeutics (DTx) to engage in dialogues surrounding the establishment of the industry in Asia, launched at the Novotel Ambassador Hotel in Gangnam, Seoul on Tuesday.The DTx conference also has a series in America East and
HLB, a biotech firm, said Tuesday that it would apply for conditional permission for its targeted anticancer drug, rivoceranib. HLB, an affiliate of the HLB Group, holds the domestic sales right of rivoceranib.According to industry sources, HLB plans to apply to the Ministry of Food and Drug Safety
The Ministry of Food and Drug Safety has set about to become an advanced regulatory agency for artificial intelligence-based medical devices.The ministry said it hosted the regular meeting of the Artificial Intelligence Working Group within the International Medical Device Regulators’ Forum (IMDRF)
Korean thoracic and cardiovascular surgeons recently held an exhibition for the late Dr. Lee Yung-kyoon (1921-1994) to honor his legendary works in the field. Lee is known for introducing lifesaving procedures in heart disease for the first time in Korea and publishing numerous studies that shaped t
Spouses of Ambassadors in Korea had a chance to learn why Korea’s cancer mortality rate was lowest despite the lowest health cost among 21 high-income countries.The Hanaro Medical Foundation (HMF), a health checkup institution, welcomed 14 members from the Ambassadors' Spouses Association in Seoul (